Cancer Research UK logo.
SearchDonate
  • Search

A trial of ipilimumab and temozolomide for people with glioblastoma (Ipi-Glio)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with a type of brain tumour called glioblastoma. It is for people who have had treatment with:

  • surgery

  • then radiotherapy with temozolomide

Recruitment start: 21 December 2018

Recruitment end: 30 April 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Paul Mulholland

Supported by

Bristol-Myers Squibb

The National Brain Appeal

University of Oxford

University College London Hospitals

Last reviewed: 2 May 2021

CRUK internal database number: 16025

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.